Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > IR Performance

<< Previous

Bullboard Posts

Next >>

Comment by Jane101on Apr 04, 2023 11:06am

70 Views

Post# 35378604

RE:RE:RE:IR Performance

nWow you asked for material non public info and threatened her is she didn't give it to you

And then hate on her publicly!

Do you use the same tactics at your workplace? Or at your church or with women who rejected you in the past?

sad pathetic limp loser

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing